What are the best management strategies for a patient presenting with cluster headaches?

Cluster Headache Management

Acute Treatment: First-Line Options

For acute cluster headache attacks, use 100% oxygen at 12 L/min via non-rebreather mask for 15 minutes OR subcutaneous sumatriptan 6 mg—both are equally effective first-line treatments. 1, 2, 3

High-Flow Oxygen Therapy

• Administer 100% oxygen at a minimum flow rate of 12 L/min through a non-rebreather mask for 15 minutes at attack onset 1, 3, 4
• This achieves pain relief in 78% of patients at 15 minutes compared to 20% with placebo 3, 4
• Flow rates below 12 L/min are insufficient and represent a common pitfall 3
• Home oxygen concentrators (using two units connected together) are an effective alternative to oxygen tanks, providing better relief than oral zolmitriptan 5
• No adverse events occur with oxygen therapy, making it extremely safe 4, 6

Subcutaneous Sumatriptan

• Administer 6 mg subcutaneously at attack onset 1, 2, 3, 7
• Provides pain relief in 70% of patients within 1 hour and 49% within 10 minutes 7
• For cluster headache specifically, 49% achieve relief at 10 minutes and 74-75% at 15 minutes 7
• Pain-free rates reach 63-65% at 2 hours 7

Alternative Acute Treatment

• Intranasal zolmitriptan 10 mg is an alternative to subcutaneous sumatriptan 1, 2, 3
• Noninvasive vagus nerve stimulation is suggested for episodic cluster headache, particularly when medications are contraindicated or side effects are intolerable 1, 3

---

Preventive Treatment: Episodic Cluster Headache

Galcanezumab is the first-line prophylactic treatment for episodic cluster headache, with the strongest evidence among all available preventive options. 1, 2, 3

First-Line Prevention

• The VA/DoD and American Academy of Neurology recommend galcanezumab specifically for episodic (not chronic) cluster headache 1, 2, 3
• Monitor for injection site reactions and hypersensitivity 2
• Critical caveat: Galcanezumab is NOT effective for chronic cluster headache and carries a weak recommendation AGAINST its use in this population 1, 2, 3

Second-Line Prevention: Verapamil

• Use at least 240 mg daily (maximum dose depends on efficacy and tolerability) 1, 8
• Recent VA/DoD guidelines note insufficient evidence to make a strong recommendation, though it remains commonly used 1
• Obtain baseline ECG before initiating therapy 1
• Monitor PR interval with ECG when using doses >360 mg daily, as cluster headache doses may be double those used in cardiology 1
• Do not give to patients with impaired ventricular function, heart failure, or wide-complex tachycardias 1

Transitional/Bridge Therapy: Corticosteroids

• Use at least 100 mg prednisone (or equivalent) orally, or up to 500 mg IV per day over 5 days, then taper 1, 8
• Provides rapid effect while waiting for preventive medications to become effective 8
• Preventive therapy may take 2-3 months for oral medications and 3-6 months for monoclonal antibodies to reach full effectiveness 3

Alternative Preventive Options

• Lithium and topiramate are recommended as alternative treatments when first-line options fail or are contraindicated 1, 8

---

Preventive Treatment: Chronic Cluster Headache

For chronic cluster headache, verapamil remains the most commonly used option, though evidence is insufficient for a strong recommendation; galcanezumab should NOT be used. 1, 2

• There is insufficient evidence to recommend for or against verapamil for chronic cluster headache prevention 1
• Galcanezumab has a weak recommendation AGAINST its use in chronic cluster headache 1, 2
• Follow the same verapamil dosing and monitoring guidelines as for episodic cluster headache 1

---

Treatment Algorithm

At Attack Onset

1. Immediately administer either:
   • 100% oxygen at 12 L/min via non-rebreather mask for 15 minutes 1, 3, 4, OR
   • Subcutaneous sumatriptan 6 mg 1, 2, 7
2. If inadequate response at 15 minutes, consider rescue medication 7

For Prevention (Episodic)

1. Start galcanezumab as first-line prophylaxis 1, 2, 3
2. Consider corticosteroids (prednisone 100 mg daily for 5 days, then taper) as bridge therapy while waiting for galcanezumab to take effect 8
3. If galcanezumab fails or is contraindicated, use verapamil starting at 240 mg daily with appropriate cardiac monitoring 1, 8
4. If verapamil fails, consider lithium or topiramate 8

For Prevention (Chronic)

1. Start verapamil at 240 mg daily with cardiac monitoring 1
2. Consider lithium or topiramate as alternatives 8
3. Do NOT use galcanezumab 1, 2

---

Critical Pitfalls to Avoid

• Never use oxygen flow rates below 12 L/min—this is inadequate for cluster headache treatment 3
• Never prescribe galcanezumab for chronic cluster headache 1, 2, 3
• Never confuse acute and prophylactic treatments—oxygen and sumatriptan are for attacks, not prevention 2
• Avoid oral ergot alkaloids, opioids, or barbiturates due to poor efficacy, toxicity, and dependency risks 3
• Do not use implantable sphenopalatine ganglion stimulator—insufficient evidence and weak recommendation against 1, 3
• Always obtain baseline ECG before starting verapamil and monitor when doses exceed 360 mg daily 1

---

Lifestyle and Trigger Management

• Advise patients to avoid strong smells (tobacco, nail polish, petroleum) that can trigger attacks 2
• Consider avoiding nitrate-containing foods (processed meats, aged cheeses) as potential triggers 3